000			03814nam a22004095i 4500
999			_c391358 _d391358
001			391358
003			ES-MaUEC
005			20230626125555.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			201130s2021 xxu| o |||| 0|eng d
020			_a9781071610527
024	7		_a10.1007/978-1-0716-1052-7 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280 .B7 _b2021 EB
245	0	0	_aNanotherapy for Brain Tumor Drug Delivery _cedited by Vivek Agrahari, Anthony Kim, Vibhuti Agrahari
250			_a1st edition 2021
264		1	_aNew York, NY _bSpringer International Publising _c2021
300			_a1 recurso en línea (XIII, 298 páginas) _b53 ilustraciones, 46 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aNeuromethods _x1940-6045 _v163
505	0		_aGlioblastoma: State of Art of Treatments and Application of Polymeric and Lipidic Nanomedicines -- Passive and Active Targeting of Brain Tumors -- Strategies to Modulate the Blood Brain Barrier for Directed Brain Tumor Targeting -- Drug Delivery Approaches and Imaging Techniques for Brain Tumor -- Surface-Modified Nano-Drug Carriers for Brain Cancer Treatment -- Inorganic Nanostructures for Brain Tumor Management -- Strategies to Enhance the Distribution of Therapeutic Nanoparticles in the Brain by Convection Enhanced Delivery -- Focused Ultrasound-Mediated Blood-Brain Barrier Disruption for Enhanced Drug Delivery to Brain Tumors -- Neurosurgical Implant-Based Strategy for Brain Cancer Therapy -- Liposome-Templated Hydrogel Nanoparticles for Targeted Delivery of CRISPR/Cas9 to Brain Tumors -- Methods to Separate, Characterize, and Encapsulate Drug Molecules into Exosomes for Targeted Delivery and Treatment of Glioblastoma -- Establishing Orthotopic Xenograft Glioblastoma Models for Use in Preclinical Development.
520			_aThis volume provides a guide on nanoformulations and other drug delivery approaches for both academic and industry scientists. The chapters in this book cover diverse topics and techniques in nanoparticle drug delivery, gene therapy, neurosurgical brain implant, exosomes, MRI-guided focused ultrasound (MRgFUS), and advanced preclinical glioblastoma multiforme animal models. Some chapters discuss state-of-the-art and innovative nanomedicines for glioblastoma, surface-modified nanoparticle drug carriers for brain cancer treatment, focused ultrasound (FUS)-mediated blood-brain barrier disruption for enhanced drug delivery to brain tumors; gene therapy delivery approaches to treat brain cancer, and a liposome-template hydrogel nanoparticles (LHNPs) as a powerful CRISPR/Cas9 delivery vehicle. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and thorough, Nanotherapy for Brain Tumor Drug Delivery is a valuable resource for the scientific community working on this important therapeutic field, and will help fast-track the clinical translation of revolutionary nanotechnologies for treating brain tumors. .
988			_aSpringer_Protocols_2021
650		7	_2embne _9214753 _aCerebro _xTumores
650		7	_2embne _9158453 _aNanotecnología
776	0	8	_iPrinted edition: _z9781071610510
776	0	8	_iPrinted edition: _z9781071610534
776	0	8	_iPrinted edition: _z9781071610541
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-1052-7 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2023 _dz _eu _zSI